Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/15/15 → 12/5/20 |
Funding
- Rebiotix Inc: $53,325.00
15-ID-200: An Open-label Safety Assessment of Rebiotix RBX2660 (microbiota suspension) for the Treatment of Recurrent Clostridium difficile Infection (PUNCH SOS)
- Greenberg, Richard (PI)